Ontario Health Insurance Plan

Avalon Healthcare Solutions Announces New Relationship With SelectHealth

Retrieved on: 
星期五, 十月 29, 2021

TAMPA, Fla., Oct. 29, 2021 /PRNewswire/ -- Avalon Healthcare Solutions, LLC, DBA Avalon Healthcare Solutions, is pleased to announce a new relationship to provide laboratory benefits management to SelectHealthon September 22, 2021.

Key Points: 
  • TAMPA, Fla., Oct. 29, 2021 /PRNewswire/ -- Avalon Healthcare Solutions, LLC, DBA Avalon Healthcare Solutions, is pleased to announce a new relationship to provide laboratory benefits management to SelectHealthon September 22, 2021.
  • Avalon and SelectHealth are focused on using the latest technology, evidence-based medicine, and provider education to ensure appropriate high-quality, cost-effective laboratory services to drive care for SelectHealth members.
  • "We are excited to work with Avalon to help ensure evidence-based laboratory testing," said Dr. Stephen Barlow, SelectHealth Senior Medical Director.
  • Avalon Healthcare Solutions is the world's first and only Lab Insights company, bringing together our proven Lab Benefit Management solutions, lab science expertise, digitized lab values, and proprietary analytics to help healthcare insurers proactively inform appropriate care, reduce costs, and improve clinical outcomes.

Crescita Acquires Minority Interest in The Best You®

Retrieved on: 
星期二, 九月 7, 2021

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has completed the acquisition of a minority interest in Akyucorp Ltd. d/b/a The Best You, a privately-held network of six medical aesthetic clinics in the province of Ontario (The Best You).

Key Points: 
  • Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has completed the acquisition of a minority interest in Akyucorp Ltd. d/b/a The Best You, a privately-held network of six medical aesthetic clinics in the province of Ontario (The Best You).
  • In consideration for the minority interest investment, Crescita will issue 470,128, or 2.2% of its common shares (the Common Shares), at a price of $0.70 per Common Share.
  • The Convertible Note will bear interest at variable rates based on the annual volume of purchases of Crescita products and is convertible at Crescitas option into an additional equity interest in The Best You.
  • Dr. Deniz Akyurekli, MD, Founder and Chief Medical Officer of The Best You, said, At the Best You, we help customers look and feel their best to enhance their overall well-being and quality of life.

Media Alert: Maple Launches COVID-19 Online Screening Program Covered by OHIP in Ontario and Free Virtual Clinic Platform for Doctors

Retrieved on: 
星期一, 三月 16, 2020

TORONTO, March 16, 2020 /CNW/ -Starting Tuesday, March 17, Maple, a leading virtual care platform in Canada, will provide OHIP covered online coronavirus (COVID-19) screenings with a live physician to all Ontario residents.

Key Points: 
  • TORONTO, March 16, 2020 /CNW/ -Starting Tuesday, March 17, Maple, a leading virtual care platform in Canada, will provide OHIP covered online coronavirus (COVID-19) screenings with a live physician to all Ontario residents.
  • Covered online medical visits are also available in BC for those with a valid BC Services Card.
  • Ontario and BC are the only provinces that currently allow doctors to see patients in this way under provincial health plans.
  • Maple's virtual clinic platform, which is being offered to all Ontario and BC doctors free of charge during this time, will allow physicians across both provinces to rapidly launch virtual care capabilities from their home, office, or clinic.

Ontario government to end OHIP+ coverage for young people with private drug plans

Retrieved on: 
星期四, 二月 21, 2019

TORONTO, Feb. 21, 2019 /CNW/ - Morneau Shepell has released the February 2019 issue of its monthly newsletter, News & Views , in which the company looks at the following topics:

Key Points: 
  • TORONTO, Feb. 21, 2019 /CNW/ - Morneau Shepell has released the February 2019 issue of its monthly newsletter, News & Views , in which the company looks at the following topics:
    Ontario to end OHIP+ drug coverage for young people with private drug plans On January 2, 2019, the Ontario government released a regulatory notice and draft regulation that will make OHIP+ drug coverage only available to Ontarians under the age of 25 who do not have drug coverage through a private drug benefit plan.
  • Those under the age of 25 without private drug benefit coverage will continue to have access to approximately 4,400 drugs included in the Ontario Drug Benefit Formulary.
  • The plans will continue to be under the jurisdiction of the Employment Pension Plan Act and the Alberta Superintendent of Pensions.
  • Tracking the funded status of pension plans as at January 31, 2019 Morneau Shepell describes the funded status of pension plans at end of 2018 based on three typical investment portfolios.

Innovative Medicines Canada applauds the changes to OHIP+

Retrieved on: 
星期二, 七月 3, 2018

Innovative Medicines Canada member companies play an important role in the health care system by bringing new and important treatments to Canada to improve the lives of Ontarians.

Key Points: 
  • Innovative Medicines Canada member companies play an important role in the health care system by bringing new and important treatments to Canada to improve the lives of Ontarians.
  • "Innovative Medicines encourages the Ontario government to invest a portion of the savings into ensuring access to more life-changing medicines on its public plan."
  • As the province of Ontario moves forward withthe changes to OHIP+, Innovative Medicines Canada looks forward to work with the provincial government to create the best possible access to prescription medicines for Ontarians and all Canadians.
  • Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry.

CLHIA welcomes the announcement of changes to OHIP+

Retrieved on: 
星期六, 六月 30, 2018

TORONTO, June 30, 2018 /CNW/ - The Canadian Life and Health Insurance Association (CLHIA) welcomes the changes to OHIP+ announced today by the Ontario Minister of Health and Long-Term Care Christine Elliott.

Key Points: 
  • TORONTO, June 30, 2018 /CNW/ - The Canadian Life and Health Insurance Association (CLHIA) welcomes the changes to OHIP+ announced today by the Ontario Minister of Health and Long-Term Care Christine Elliott.
  • "The changes will also ensure the health benefit plans that Ontario families value remain strong and sustainable," he added.
  • "We congratulate the new Ontario government on moving decisively on this matter that will benefit all Ontarians," concluded Mr. Frank.
  • The CLHIA represents life and health insurance companies accounting for 99% of the business in Canada.